It also face criticism for its reliance on Siam Bioscience, which is owned by the country's king and had no previous experience in vaccine production.
News
- Thais debut locally made AstraZeneca but supplies are tight
- Wyoming startup accelerator gives boost to businesses
“This is one of only a few truly carbon-negative biotech technologies available today,” he said. On Tuesday, Yeatts said his company is a few months ...
- This Louisiana town is on the forefront of heart research
In one ongoing study that began in 2013, Dr. Owen Carmichael, a brain health researcher at the Pennington Biomedical Research Center, started ...
- Initial public offerings scheduled to debut next week
... managed by Spartan Securities. Proposed Nasdaq symbol ALZN. Business: Preclinical biotech developing therapies for Alzheimer's disease. 00:00.
- Jay Peak ski area receiver reaches $32.5M settlement
... failed plan to build a biotechnology plant in northern Vermont using millions of foreign investors' money raised through the EB-5 visa visa program.